These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 21823916

  • 1. An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate.
    Hergüner S, Tanidir C.
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):383-4. PubMed ID: 21823916
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract] [Full Text] [Related]

  • 5. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network.
    Arch Gen Psychiatry; 2005 Nov 30; 62(11):1266-74. PubMed ID: 16275814
    [Abstract] [Full Text] [Related]

  • 6. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B.
    Pediatrics; 2006 Sep 30; 118(3):e704-10. PubMed ID: 16950962
    [Abstract] [Full Text] [Related]

  • 7. The effect of methylphenidate and placebo on eye-hand coordination functioning and handwriting of children with attention deficit hyperactivity disorder.
    Lufi D, Gai E.
    Neurocase; 2007 Oct 30; 13(5):334-41. PubMed ID: 18781432
    [Abstract] [Full Text] [Related]

  • 8. [Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder].
    Tomás Vila M, Aleu Pérez-Gramunt M, Beseler Soto B, Benac Prefasi M, Pantoja Martínez J, Pitarch Castellano I.
    An Pediatr (Barc); 2010 Aug 30; 73(2):78-83. PubMed ID: 20605120
    [Abstract] [Full Text] [Related]

  • 9. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R, Gross-Tsur V.
    Harefuah; 1997 May 01; 132(9):672-5. PubMed ID: 9225587
    [No Abstract] [Full Text] [Related]

  • 10. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R, Hodgkins P, Meijer W.
    Curr Med Res Opin; 2010 Nov 01; 26(11):2565-74. PubMed ID: 20863165
    [Abstract] [Full Text] [Related]

  • 11. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA.
    Arch Gen Psychiatry; 2007 Feb 01; 64(2):218-24. PubMed ID: 17283289
    [Abstract] [Full Text] [Related]

  • 12. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
    Olfson M, Marcus SC, Zhang HF, Wan GJ.
    J Clin Psychopharmacol; 2008 Apr 01; 28(2):255-7. PubMed ID: 18344749
    [No Abstract] [Full Text] [Related]

  • 13. Methylphenidate (Ritalin) use and abuse.
    Crutchley A, Temlett JA.
    S Afr Med J; 1999 Oct 01; 89(10):1076-9. PubMed ID: 10582063
    [No Abstract] [Full Text] [Related]

  • 14. [Methylphenidate double-blind trial: indication and performing].
    Bliznakova L, Gerstner S, Schmidt MH, Becker K.
    Klin Padiatr; 2007 Oct 01; 219(1):9-16. PubMed ID: 17205427
    [Abstract] [Full Text] [Related]

  • 15. Explosive outbursts associated with methylphenidate.
    Adrian N.
    J Am Acad Child Adolesc Psychiatry; 2001 Jun 01; 40(6):618-9. PubMed ID: 11392335
    [No Abstract] [Full Text] [Related]

  • 16. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Zarinara AR, Mohammadi MR, Hazrati N, Tabrizi M, Rezazadeh SA, Rezaie F, Akhondzadeh S.
    Hum Psychopharmacol; 2010 Nov 01; 25(7-8):530-5. PubMed ID: 20860068
    [Abstract] [Full Text] [Related]

  • 17. [Methylphenidate. A possibility for rare hyperactive children].
    Rev Infirm; 2004 Sep 01; (103):39-40. PubMed ID: 15517803
    [No Abstract] [Full Text] [Related]

  • 18. Treatment for kleptomania.
    Feeney DJ, Klykylo WM.
    J Am Acad Child Adolesc Psychiatry; 1997 Jun 01; 36(6):723-4. PubMed ID: 9183125
    [No Abstract] [Full Text] [Related]

  • 19. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P, Weizman A.
    Psychosomatics; 2009 Jun 01; 50(2):178. PubMed ID: 19377031
    [No Abstract] [Full Text] [Related]

  • 20. Does methylphenidate influence cognitive performance?
    Solanto MV.
    J Am Acad Child Adolesc Psychiatry; 1997 Oct 01; 36(10):1323-5. PubMed ID: 9334541
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.